Injection of TGFβR negative CAFs may promote growth of prostate cancer cell in the bone in comparison to TGFβR positive CAFs [93], but it is also reported that inhibition of TGFβ signaling decrease the growth of prostate cancer cells in bone [99]. Here, TGFB1 is linked to prostate carcinoma.